Roche's Genentech unit has forged an alliance with Astex, worth up to $515 million, to partner on a fragment-based drug ...

Novartis has reached a deal to buy Myricx Bio for up to $1.5 billion, giving it control of the London, UK, start-up's ...

The NHS will include an AI-powered triage tool in the NHS App in an attempt to cut waiting lists and improve care for ...

Sir Chris Hoy has said he feels "very proud" when he hears of people taking part in the charity cycling event he set up last ...

A series of pilot schemes set up by the UK in partnership with the pharma industry will test ways to get new medicines to ...

As the US relaxes an export ban on Anthropic's advanced AI tools, the company formally launched Claude Science, an AI 'workbench' for researchers involved in drug discovery. Claude Science is the ...

Orca Bio has become a commercial-stage company with the FDA approval of Tregzi, a cell-based immunotherapy designed to ...

Roche's chief medical officer, Levi Garraway. Roche has thrown down the gauntlet to Amgen and Bristol Myers Squibb with new ...

For the first time, children in the US as young as two with the blood disorders sickle cell disease and beta thalassaemia are ...

AstraZeneca has returned to China's CSPC Pharma to fill its R&D pipeline, reaching a new agreement to develop drugs for ...

A study has found that nearly half of all cases of dementia are avoidable with lifestyle changes, but public health campaigns ...